Associations Between NBS1 Polymorphisms, Haplotypes and Smoking-Related Cancers

Sungshim L. Park,Delara Bastani,Binh Y. Goldstein,Shen-Chih Chang,Wendy Cozen,Lin Cai,Carlos Cordon-Cardo,Baoguo Ding,Sander Greenland,Na He,Shehnaz K. Hussain,Qingwu Jiang,Yuan-Chin A. Lee,Simin Liu,Ming-Lan Lu,Thomas M. Mack,Jenny T. Mao,Hal Morgenstern,Li-Na Mu,Sam S. Oh,Allan Pantuck,Jeanette C. Papp,Jianyu Rao,Victor E. Reuter,Donald P. Tashkin,Hua Wang,Nai-Chieh Y. You,Shun-Zhang Yu,Jin-Kou Zhao,Zuo-Feng Zhang
DOI: https://doi.org/10.1093/carcin/bgq096
2010-01-01
Carcinogenesis
Abstract:Constituents of tobacco smoke can cause DNA double-strand breaks (DSBs), leading to tumorigenesis. The NBS1 gene product is a vital component in DSB detection and repair, thus genetic variations may influence cancer development. We examined the associations between NBS1 polymorphisms and haplotypes and newly incident smoking-related cancers in three case-control studies (Los Angeles: 611 lung and 601 upper aero-digestive tract (UADT) cancer cases and 1040 controls; Memorial Sloan-Kettering Cancer Center: 227 bladder cancer cases and 211 controls and Taixing, China: 218 esophagus, 206 stomach, 204 liver cancer cases and 415 controls). rs1061302 was associated with cancers of the lung [adjusted odds ratio (ORadj) = 1.6, 95% confidence interval (CI): 1.2, 2.4], larynx (ORadj = 0.56, 95% CI: 0.32, 0.97) and liver (ORadj = 1.7, 95% CI: 1.0, 2.9). Additionally, positive associations were found for rs709816 with bladder cancer (ORadj = 4.2, 95% CI: 1.4, 12) and rs1063054 with lung cancer (ORadj = 1.6, 95% CI: 1.0, 2.3). Some associations in lung and stomach cancers varied with smoking status. CAC haplotype was positively associated with smoking-related cancers: lung (ORadj = 1.7, 95% CI: 1.1, 2.9) and UADT (ORadj = 2.0, 95% CI: 1.1, 3.7), specifically, oropharynx (ORadj = 2.1, 95% CI: 1.0, 4.2) and larynx (ORadj = 4.8, 95% CI: 1.7, 14). Bayesian false-discovery probabilities were calculated to assess Type I error. It appears that NBS1 polymorphisms and haplotypes may be associated with smoking-related cancers and that these associations may differ by smoking status. Our findings also suggest that single-nucleotide polymorphisms located in the binding region of the MRE-RAD50-NBS1 complex or microRNA targeted pathways may influence tumor development. These hypotheses should be further examined in functional studies.
What problem does this paper attempt to address?